In this downloadable slideset, Andrew D. Zelenetz, MD, PhD, examines the potential of combining BTK inhibitors with other therapies in patients with B-cell malignancies.
In this downloadable slideset, Ian W. Flinn, MD, PhD, examines optimal treatment approaches with BTK inhibitors in patients with B-cell malignancies.
In this downloadable slideset, John C. Byrd, MD, discusses strategies for managing treatment-related adverse effects with BTK inhibitors in patients with B-cell malignancies.
In this downloadable slideset, John C. Byrd, MD, provides the rationale for targeting BTK with inhibitors in patients with B-cell malignancies.
In this on-demand Webcast of a CCO symposium at ASCO 2019, expert faculty review and discuss the latest data on using BTK inhibitors in the treatment of patients with B-cell malignancies.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.